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Abstract: Recent advances in synthetic biology and an emerging algal biotechnology market
have spurred a prolific increase in the availability of molecular tools for cyanobacterial research.
Nevertheless, work to date has focused primarily on only a small subset of model species, which
arguably limits fundamental discovery and applied research towards wider commercialisation. Here,
we review the requirements for uptake of new strains, including several recently characterised
fast-growing species and promising non-model species. Furthermore, we discuss the potential
applications of new techniques available for transformation, genetic engineering and regulation,
including an up-to-date appraisal of current Clustered Regularly Interspaced Short Palindromic
Repeats/CRISPR associated protein (CRISPR/Cas) and CRISPR interference (CRISPRi) research in
cyanobacteria. We also provide an overview of several exciting molecular tools that could be ported
to cyanobacteria for more advanced metabolic engineering approaches (e.g., genetic circuit design).
Lastly, we introduce a forthcoming mutant library for the model species Synechocystis sp. PCC 6803
that promises to provide a further powerful resource for the cyanobacterial research community.
Keywords: CRISPR/Cas; CRISPRi; genetic circuits; genome engineering; inteins; genome-scale
models; mutant library; optogenetics; serine integrase; sigma factors; synthetic biology
1. Introduction
Cyanobacteria are a diverse phylum of photosynthetic prokaryotes that are found in a wide variety
of marine and freshwater habitats [1–4]. Oxygenic photosynthesis evolved approximately 2.5 billion
years ago in the predecessors to modern-day cyanobacteria [5]. Their early success led to a significant
increase in free oxygen (O2) in the Earth’s atmosphere and the subsequent evolution of most aerobic
organisms [6–8]. Today, cyanobacteria account for 20%–30% of global carbon dioxide (CO2) fixation [9].
The ability of cyanobacteria to convert captured carbon into a wide variety of complex organic
molecules makes them promising platforms for the sustainable production of biofuels and high-value
chemicals [10–12]. Compared to plants, cyanobacteria offer several advantages for biotechnological
applications, including (1) higher photosynthetic efficiencies [13,14], (2) capacity to grow in hostile living
environments (e.g., in extremes of temperature, salinity and pH) [1,3,4], (3) the ability to be cultured on
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non-arable land with minimal nutrients [15], and (4) the relatively rapid and inexpensive generation of
mutants (predominantly in model species) [16]. Moreover, chloroplasts descend from an internalised
cyanobacterium [17], thus certain physiological and biochemical features are conserved in eukaryotic
photosynthetic organisms, making cyanobacteria excellent chassis for production of plant-derived
natural products, such as terpenes [18,19]. Currently, several companies are investigating the use of
cyanobacteria for producing biochemicals, including biofuels (Algenol), inks (Living Ink Technologies)
and pigments for food and cosmetics (DIC Corp., Lumen Bioscience, ScotBio). Nevertheless, several
hurdles still need to be overcome for more widespread industrial adoption.
One key issue has been the relatively slow growth rates of cyanobacterial species, including
those developed as models such as Synechocystis sp. PCC 6803 (PCC 6803) and Synechococcus elongatus
PCC 7942 (PCC 7942). For example, PCC 6803 has a doubling-time of ca. 7 h under standard growth
conditions [20], compared to 20 min for Escherichia coli and 2 h for Saccharomyces cerevisiae [21,22].
Recently, several genetically tractable cyanobacterial species have been characterised with faster
growth rates that are comparable with S. cerevisiae [20,23,24]. In this review, we will discuss these
strains and other non-model species that demonstrate the potential for cyanobacteria to close the gap
between industrially viable heterotrophic and phototrophic bio-platforms or are useful organisms for
investigating unique aspects of cyanobacterial biology and how they adapt to different environments.
A further significant challenge limitation has been the limited availability of molecular tools to
engineer cyanobacteria. However, the past few years have seen a rapid proliferation of characterised
tools and parts for cyanobacteria, including CRISPR/Cas-based systems [25–28]. This has driven the
widespread adoption of the synthetic biology paradigm for the design of biological tools based on the
bottom-up approach of recombining standardised parts or modules (e.g., promoters, ribosome binding
sites (RBS), coding sequences and terminators) [29–35]. Many of those tools were initially developed in
E. coli or S. cerevisiae and have been adapted and modified for use in cyanobacteria [36,37]. A significant
drawback is that they may behave differently in cyanobacteria and between different cyanobacterial
species. Thus, the functionality of all new tools ported for cyanobacterial applications must first be
validated [35,38]. Here, we will outline several recent developments in genome engineering using
CRISPR/Cas and recombinase approaches, as well as the opportunities and limitation of recent tools
developed in E. coli that show promise for cyanobacterial research and biotechnology applications.
To date, 290 draft genomes and 85 full genomes are available online in the CyanoBase database
(http://genome.microbedb.jp/cyanobase [39]). The growing availability of cyanobacterial genome
sequencing data has helped to foster the development of genome-scale models (GSMs) for a variety
of species, ranging from model species (e.g., PCC 6803) to the industrial relevant strain Arthrospira
(Spirulina) platensis NIES-39 [40–43]. As with E. coli [44], GSMs have allowed cyanobacterial researchers
to adopt a systems biology approach to propose and predict the outcomes of engineering strategies.
Here, we will also highlight examples where GSMs have successfully guided efforts to modify
metabolism to improve production in cyanobacteria and how GSMs could drive an increase in available
cyanobacterial omics data.
Finally, we will introduce a forthcoming barcoded mutant library in PCC 6803 called CyanoSource.
CyanoSource will be a powerful tool to develop a deeper understanding of metabolism in PCC
6803, guide work in other species (including new fast-growing strains) and will set a benchmark for
high-throughput research in the cyanobacterial field.
2. “Non-Model” Species: Requirements for Uptake and Genetic Manipulation
Cyanobacterial research has focused primarily on model organisms that are straightforward to
culture under laboratory conditions, amenable to genetic modification and can be frozen for long-term
storage [16,45–47]. The uptake of more recalcitrant, non-model species for laboratory research can
present significant challenges. Table 1 outlines some basic features that are desirable for culturing and
engineering. Below, we have highlighted several new or known “non-model” cyanobacteria, including
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their potential benefits, challenges for widespread uptake and industrial usage, and where applicable,
progress towards efficient genetic manipulation (Table 2).
Table 1. Desirable features required for culturing and genetically engineering cyanobacterial strains.
(1) Capacity to grow on agar plates and generate isolated colonies.
(2) Amenability to heterologous DNA uptake, either naturally using native DNA import systems [33,48], or
via conjugation (i.e., tri- or bi-parental mating) or electroporation.
(3) Sensitivity to antibiotics for selection following DNA uptake [49].
(4) Lack of native endonucleases that digest heterologous DNA. If present, the efficiency of DNA uptake can
be improved by selecting for strains where endonucleases have been inactivated [48]. Otherwise specific
methylases, restriction inhibitors and liposomes could be employed during delivery [50–53].
(5) Ability to take up broad-host-range self-replicating plasmids (e.g., RSF1010-based) for heterologous
gene expression.
(6) Capacity for genomic integration via allelic exchange (e.g., homologous recombination (HR) to facilitate
the generation of gene knockouts or genomic integration of gene expression cassettes. Ideally, species
will be amenable to the generation of unmarked mutants, which is important for industrial applications.
Unmarked mutants can be generated using negative selection markers (e.g., sacB) [16,54] or by
CRISPR/Cas [25].
2.1. The Emergence of Fast-Growing and Stress-Tolerant Synechococcus Strains
Cyanobacterial strains that can achieve growth rates comparable with heterotrophic microbes
could be of significant value to basic research and the biotechnology industry. Recently, three new
Synechococcus strains have been reported with high growth rates: Synechococcus elongatus UTEX 2973
(UTEX 2973), Synechococcus elongatus PCC 11801 (PCC 11801) and Synechococcus sp. PCC 11901
(PCC 11901). UTEX 2973 was first described in 2015 as a fast-growing, stress-tolerant strain that
was re-isolated from a previously characterised fast-growing strain that had lost the ability for fast
growth [20,55]. Under high light (>500 µmol photons m−2 s−1) and high temperatures (38–42 ◦C),
UTEX 2973 can achieve doubling times similar to that of S. cerevisiae (ca. 2 h) during the early growth
phase [20,24,56]. Under those conditions, UTEX 2973 can produce biomass twice as fast as its close
relative PCC 7942, despite only a small number of nucleotide differences between the two genomes [57].
However, growth was not examined for longer periods of time (i.e., >24 h). At lower temperatures
(30 ◦C), growth of UTEX 2973 is slower than PCC 7942 or PCC 6803 at 300 or 500 µmol photons
m−2 s−1 [35], and slower than 6803 when cultured for longer periods (up to 10 days) under high
light (750 µmol photons m−2 s−1) [24]. UTEX 2973 is not naturally competent, but is amenable to
conjugation and genome editing by CRISPR/Cas [20,58]. Furthermore, naturally transformable mutants
of UTEX 2973 have been described [33], while three point mutations in PCC 7942 can reportedly lead
to growth rates similar to that of UTEX 2973 [57]. The latter finding could have a significant impact on
cyanobacterial research as PCC 7942 is a naturally transformable and widely used model species.
PCC 11801 was isolated from India and first described in 2018 [23]. Similarly to UTEX 2973,
PCC 11801 is tolerant to high light and temperatures and exhibits fast growth rates (i.e., a doubling
time of 2.3 h). Furthermore, PCC 11801 is tolerant of high levels of NaCl (i.e., it can grow at sea salt
concentrations (ca. 0.7 M), whereas PCC 7942 cannot) and it is naturally transformable. The genome
sequence of PCC 11801 is highly similar to PCC 7942 and UTEX 2973 (ca. 83%). Thus, existing plasmid
vectors used for engineering PCC 7942 are widely compatible in PCC 11801.
One of the best-performing strains reported to date is PCC 11901, which was isolated in Singapore
from an estuarine environment enriched with nitrogen and phosphorous compounds [24]. PCC 11901
is tolerant to high light levels, achieves fast growth rates comparable to UTEX 2973, and is tolerant to
a wide range of salinities, similar to PCC 11801. Although UTEX 2973 grows faster than PCC 11901
during the early growth phase, PCC 11901 reportedly outperforms UTEX 2973 when grown for longer
time periods (i.e., >24 h). PCC 11901 accumulated 2–3 times more biomass when grown alongside PCC
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6803, PCC 7942, Synechococcus sp. PCC 7002 (PCC 7002) and UTEX 2973, achieving an OD730 = 101
and a biomass of 18.3 g dry weight per litre. PCC 11901 is naturally transformable with efficiencies
similar to that of PCC 7002, as demonstrated by the generation of markerless mutants using methods
previously described in PCC 7002 [59].
2.2. Nostoc punctiforme ATCC 29133
Nostoc punctiforme ATCC 29133 (ATCC 29133) is a nitrogen (N2)-fixing, heterocyst-forming
cyanobacterium which forms a symbiotic relationship within the coralloid roots of plants. ATCC
29133 is a useful organism for investigating symbiotic relationships between plants and N2-fixing
cyanobacteria [60]. It has also been key to understanding the biosynthetic pathway of scytonemin, a
natural sunscreen against UV damage produced by many cyanobacterial species [61]. Transformation
of ATCC 29133 was first described in 1994 [62] and has since been further developed to generate
scytonemin-deficient mutants [63]. Mutants were obtained via conjugation, either by random
transposon insertion into the open reading frame of the scytonemin biosynthesis operon or by
allelic exchange. ATCC 29133 appears amenable to selection using chloramphenicol, neomycin,
streptomycin and sacB markers.
2.3. Cyanothece sp.
Cyanothece species are a group of unicellular cyanobacteria that can perform photosynthesis and
fix N2 within the same cell via temporal separation of the two processes. N2 fixation occurs during
the dark period when O2 levels are low. They are natural contributors to N2 fixation in rice paddies,
and, therefore, could play an important role in reducing agricultural fertiliser use [64,65]. A genetic
transformation protocol for producing targeted gene knockouts in Cyanothece sp. PCC 7822 was
developed in 2010 [66], where a single-stranded DNA fragment encoding a spectinomycin resistance
cassette was electroporated into cells, leading to integration of the cassette at random points in the
genome via non-homologous recombination. Despite testing Cyanothece sp. ATCC 51142, PCC 7424,
PCC 7425, PCC 8801 and PCC 8802, mutants could only be generated in PCC 7822 via this technique.
More recently, Liberton et al. [67] reported a method for generating targeted mutations in Cyanothece sp.
ATCC 51142 using triparental mating. A plasmid encoding two methylases was required in order to
make the cargo plasmid more resistant to digestion. Using this system, a kanamycin resistance cassette
was inserted into a targeted chromosomal site.
2.4. Arthrospira sp.
Arthrospira species are the source of high-value nutraceuticals (e.g., Spirulina) and natural blue
pigments in food (e.g., the phycobiliprotein, C-phycocyanin) [68,69]. They tolerate high levels of
alkalinity and can be cultured in a variety of closed or open (e.g., race way pond) environments.
Nevertheless, Arthrospira sp. are highly resistant to genetic modification due to an abundance of native
restriction–modification systems that can rapidly degrade heterologous DNA [70]. The most efficient
transformation system reported to date used a Tn5 transposase expression cassette to generate random
integration events in the genome of Arthrospira platensis C1 and selection via a spectinomycin resistance
cassette [53]. DNA degradation was minimised by encapsulation in liposomes and mixing with a
type 1 restriction inhibitor prior to electroporation. Transformed cells resistant to spectinomycin were
reportedly stable for several months. It is tempting to speculate that delivery of a CRISPR/Cas system
with this approach could enable targeted genome editing in Arthrospira sp.
2.5. Leptolyngbya sp.
Leptolyngbya species are widely distributed in terrestrial and freshwater environments [71], and
are, therefore, of great ecological interest. Leptolyngbya sp. BL0902 is also used for the production of
biomass and bioproducts, as it can grow at a range of industrially viable temperatures, tolerate high
salt concentrations, pH extremes and variable light conditions. Growth rates in the laboratory and in
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outdoor ponds are similar to those of Arthrospira species [72]. Conjugal transformation of Leptolyngbya
sp. BL0902 (BL0902) with broad host range vectors based on RSF1010 was successfully carried
out in 2012 [72,73], although two antibiotics were required to limit the appearance of spontaneous
resistant mutants. Conjugation was used for generation of a transposon library and introduction of an
expression plasmid.
2.6. Fremyella diplosiphon
Fremyella diplosiphon is a filamentous, heterocyst-forming, freshwater species that can adjust its
photosynthetic receptors and antenna to differences in light intensity and quality. Detailed methods
for genetic manipulation are available that allow for the generation of unmarked mutants [74]. First,
the plasmid of interest is methylated to protect it from digestion in F. diplosiphon. The plasmid is then
introduced via triparental mating and transconjugates selected on plates containing neomycin [75].
Unmarked mutants can then be generated using sacB.
2.7. Marine Synechococcus sp. and Prochlorococcus sp.
Marine Synechococcus and Prochlorococcus genera are responsible for approximately a quarter of
ocean primary productivity [2], and are, therefore, of great academic interest. Genetic manipulation
of Prochlorococcus sp. (including the introduction of a heterologous plasmid) has not been reported.
However, Prochlorococcus strains can be cultured on semi-solid agar plates in the presence of specific
‘helper’ heterotrophic bacteria [76], fulfilling the initial requirement for genetic manipulation. Gene
deletion has been reported in the marine Synechococcus species WH7803, WH8102 and WH8103 [77,78].
Plasmids were introduced into cells via biparental mating or electroporation. Transformants were
plated on semi-solid (0.3% w/v) agar plates and kanamycin was used as the selectable marker. Via this
method, self-replicating and suicide plasmids were introduced, which facilitated targeted mutations.
2.8. Thermosynechococcus elongatus
Thermosynechococcus elongatus BP-1 is a thermophilic cyanobacterium with optimal growth at
55 ◦C, making it ideal for biotechnology applications that require high temperatures [79]. T. elongatus
BP-1 proteins are also ideal for purification and crystallographic studies, due to their increased stability
at high temperatures [80]. A natural transformation method for chromosomal integration has been
developed for T. elongatus BP-1, with either kanamycin or chloramphenicol used for selection of
transformants [81]. More recently, T. elongatus PKUAC-SCTE542 has been highlighted as a naturally
transformable strain with high growth rates that is sensitive to spectinomycin [82].
2.9. Chlorogloeopsis fritschii and Fischerella muscicola
Chlorogloeopsis fristchii sp. PCC 6912 and Fischerella muscicola PCC 7414 are two of the most
complex species of cyanobacteria, in that they are filamentous, heterocyst-forming strains able to
undergo multiplanar cell division and thereby create multiseriate filaments [83]. Introduction of
expression plasmids via conjugation and biolistic DNA transfer methods has been reported in both
species. Conjugation was made possible by the partial removal of the exopolysaccharide sheath by
introducing a salt washing step.
2.10. Chroococcidiopsis thermalis
Chroococcidiopsis thermalis is found in environments with extremes of temperature (both hot and
cold) [84]. Furthermore, these extremophile cyanobacteria can survive long periods of desiccation and
high levels of solar radiation that few other organisms can tolerate. C. thermalis incorporates chlorophyll
f in its photosystems, allowing absorption of far-red light not available to other photosynthetic
organisms [85]. Chroococcidiopsis species have been suggested as possible candidates for terraforming
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other planets [86]. Expression plasmids have been introduced into several strains of C. thermalis via
conjugation [84].
2.11. Gloeobacter violaceus PCC 7421
Gloeobacter violaceus PCC 7421 (PCC 7421) is a primordial cyanobacterium that lacks thylakoid
membranes [87]. PCC 7421 localises proteins involved in photosynthesis and respiration to specific
regions of the cytoplasmic membrane [88]. Despite its very slow growth, a method of transforming
PCC 7421 with an expression vector via conjugation has been developed [89].
Microorganisms 2019, 7, 409 7 of 36
Table 2. Summary of genetic manipulations carried out in model and non-model cyanobacterial species discussed in Section 2.
Species Strain Desirable Featuresfrom Table 1
Transformation
Method
Reported Selection
Markers Agar Medium References
Synechococcus sp. UTEX 2973 1), 2), 3), 4), 5), 6)
Conjugation
CRISPR/Cas
pilN mutants are
naturally
transformable
Apramycin
Chloramphenicol
Kanamycin
Spectinomycin
Streptomycin
BG-11 [20,33,35,58]
PCC 11801 1), 2), 3), 5), 6) Naturallytransformable Spectinomycin BG-11 [23]
PCC 11901 1), 2), 3), 5), 6) Naturallytransformable
Acrylic acid
Spectinomycin AD7 [24]
Nostoc punctiforme ATCC 29133 1), 2), 3), 4), 5), 6) Conjugation
Chloramphenicol
Neomycin
sacB markers
Streptomycin
Allen and Arnon [62,63,90]
Cyanothece sp. PCC 7822 1), 2), 3), 5) Electroporation Spectinomycin BG-11 [66]
ATCC 51142 1), 2), 3), 4), 6) Conjugation Kanamycin BG-11ASP2 [67]
Arthrospira platensis C1 1), 2), 3), 4), 5) Electroporation Spectinomycin Zarrouk [53]
Leptolyngbya sp. BL0902 1), 2), 3), 4), 5), 6) Conjugation
Chloramphenicol
Erythromycin
Neomycin
Spectinomycin
Streptomycin
BG-11 [72,73]
Fremyella diplosiphon SF33 1), 2), 3), 4), 6) Conjugation
Kanamycin
Neomycin
sacB markers
BG-11/HEPES [74,75,91]
Marine Synechococcus sp.
WH7803
WH8102
WH8103
1), 2), 3), 6) ConjugationElectroporation Kanamycin SN [76,77,92]
Marine Prochlorococcus sp. 1), 3) - Spectinomycin Pro99 [76,93]
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Table 2. Cont.
Species Strain Desirable Featuresfrom Table 1
Transformation
Method
Reported Selection
Markers Agar Medium References
Thermosynechococcus elongatus BP-1 1), 2), 3), 4), 5), 6) Naturallytransformable
Chloramphenicol
Kanamycin BG-11 [81]
PKUAC-SCTE542 1), 2), 3), 6) Naturallytransformable Spectinomycn BG-11 [82]
Chlorogloeopsis fritschii PCC 6912 1), 2), 3), 4), 5) BiolisticConjugation
Kanamycin
Neomycin Allen and Arnon [83,90]
Fischerella muscicola PCC 7414 1), 2), 3), 4), 5) BiolisticConjugation
Kanamycin
Neomycin Allen and Arnon [83,90]
Chroococcidiopsis thermalis 1), 2), 3), 4), 5) Conjugation Neomycin BG-11 [84]
Gloeobacter violaceus PCC 7421 1), 2), 3), 4), 5) Conjugation Streptomycin BG-11 [89]
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3. Current and Future Strategies for Genome Engineering in Cyanobacteria
3.1. CRISPR/Cas Genome Editing in Cyanobacteria
The RNA-guided CRISPR/Cas family of enzymes has been the driving force for a revolutionary step
change in precision genome editing capacity in almost every field of biology, including photosynthetic
biology [94–96]. Briefly, all CRISPR/Cas genome editing systems exploit the Class II family of
CRISPR-associated endonuclease (Cas) enzymes (comprising types II, V and VI Cas) [97,98]. The type
II-A Cas of Streptococcus pyogenes (SpCas9) was first demonstrated as a site-specific RNA-guided DNA
cleavage tool by Jinek et al. [99]. Since then, a vast array of CRISPR/Cas technologies have been
produced and continue to be developed at a rapid pace [100–105]. Genome editing studies using
CRISPR/Cas have now been reported in several cyanobacterial species, including PCC 6803, PCC 7942,
UTEX 2973 and the filamentous strain Nostoc (Anabaena) PCC 7120, from four separate labs (for recent
reviews, see [25,27,106]).
We will not cover the specific mechanisms of all the available CRISPR/Cas tools here (for reviews,
see [94,96]). We will focus on Cas9, which confers a blunt-ended double-stranded break (DSB) in
DNA (Figure 1A), and type V-A Cas (Cas12a, or previously Cpf1), which produces a staggered DSB
(Figure 1B) [107]. Use of CRISPR/Cas systems for gene editing relies on a synthetic single-guide
RNA (sgRNA or gRNA), which, for Cas9, is a fusion of a crRNA (CRISPR-RNA) and a tracrRNA
(trans-activating crRNA). For CRISPR/Cas9 systems, gRNAs are commonly expressed from a DNA
template, with each gRNA transcribed from a single expression cassette. The crRNA component is
customised for targeting a specific genomic locus and the tracrRNA acts as a scaffold for recruitment of
Cas9. In contrast, Cas12a enzymes possess an intrinsic RNase activity that facilitates autoprocessing of
gRNAs that can be expressed from ‘spacer arrays’ (Figure 1C) and a tracrRNA fusion is not required.
Spacer arrays are comprised of spacers that code for gRNAs, which are each separated by a direct
repeat (DR). The DR facilitates recognition and cleavage of the precursor RNA by Cas12a to form
mature gRNAs. To date, all Cas isoforms that target DNA require a 2–6 nucleotide sequence called a
protospacer-adjacent motif (PAM) site for Cas to bind DNA and generate a DSB. Depending on the
type of Cas used, PAM sites are situated immediately upstream or downstream of the gRNA target
locus. As PAM sites are sequence-specific, the choice of Cas enzyme used can impact on the gRNA
loci available.
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direct repeat regions (DRs, white). Cas12a recognises and cleaves spacers in response to a DR to 
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(typical length indicated as 18–22 nucleotides), which blocks RNA polymerase (RNAP, blue) to 
prevent mRNA (red) synthesis. (E) Example of transcriptional activation by CRISPRa. DNase inactive 
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grey). The scRNA recruits an RNA binding protein (RBP, pink) fused to a transcriptional activator 
(green) (e.g., [108]), which subsequently leads to activation of RNAP and transcription elongation. 
Figure 1. Basic overview of CRISPR/Cas-based genome editing and CRISPR interference in
cyanobacteria. (A) The type II- RISPR/Cas system comprising SpCas9 that is targeted by a
guide RNA (gRNA, green) upstream of an NGG protospacer adjacent motif (PAM) (red). SpCas9
gener tes a blunt-en ed double-strand d break (DSB) in DNA (black dashed line). (B) The type II-V
CRISPR/Cas system comprising FnCas12a that is tar t y a gRNA downstream of a TTN PAM.
Cas12a confers a staggered DSB in DNA that results in a five-nucleotide overhang. (C) Illustration
of a single expression cassette containing three spacers (i.e., a spacer array, orange) that are flanked
by direct repeat regions (DRs, white). Cas12a recognises and cleaves spacers in response to a DR to
generate a mature gRNA from each spacer. (D) Overview of transcriptional inhibition by CRISPRi.
DNase inactive Cas enzymes (e.g., dCas9 or ddCas12a) are targeted to a DNA locus by a gRNA (typical
length indicated as 18–22 nucleotides), which blocks RNA polymerase (RNAP, blue) to prevent mRNA
(red) synthesis. (E) Example of transcriptional activation by CRISPRa. DNase inactive Cas enzymes
(e.g., dCas9 or ddCas12a) are targeted by a gRNA fused to a scaffold RNA (scRNA, grey). The scRNA
recruits an RNA binding protein (RBP, pink) fused o transcriptional activator (gr e ) (e.g., [108]),
which subsequently leads to activation of RNAP and transcription elongation.
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In cyanobacteria (as in other prokaryotes that lack an endogenous non-homologous end joining
(NHEJ) pathway) [109,110]), CRISPR/Cas has been used as an enhancement tool to improve the
frequency of targeted mutation by HR [58,111–113]. In brief, expression of Cas and a gRNA mediates
cleavage at a specific DNA target site. The co-expressed editing template contains homology flanks
(ca. 1 kb in length) and subsequent repair modifies the locus and mutates the PAM site to avoid
repeated cleavage. The potential advantages of CRISPR/Cas over established HR strategies in model
cyanobacteria such as PCC 6803 [16] are that 1) a markerless mutation is induced at the DNA target
site in a single event; 2) multiple sites could be modified simultaneously, provided the appropriate
gRNAs and editing templates are co-expressed; and 3) CRISPR/Cas systems could be more efficient
for engineering species that are not naturally transformable (e.g., by conjugation or electroporation).
Potential drawbacks include toxicity of the Cas enzyme and the time required to cure new mutants of
the CRISPR/Cas vector following editing. One approach to accelerate the latter issue is the inclusion
of a negative selection marker (e.g., sacB) on the CRISPR/Cas vector [113]. Thus far, SpCas9 is the
only Cas9 reported to have been expressed in cyanobacterial strains, including PCC 6803, PCC 7942
and UTEX 2973 (Table 3) [58,111,112]. Expression of SpCas9 has been linked to toxicity and failure to
recover colonies following transformation or conjugation in all three species, even at low expression
levels. It remains unclear why SpCas9 appears toxic in cyanobacteria, or whether other Cas9 enzymes
may be more compatible.
Table 3. Cyanobacterial species where CRISPR/Cas has been used for gene editing.
Species and Strain Cas Type Expression System Reference
Synechococcus elongatus PCC 7942 SpCas9 episomal [111]
Synechocystis sp. PCC 6803
FnCas12a episomal [114]Synechococcus elongatus UTEX 2973
Nostoc sp. PCC 7120
Synechococcus elongatus UTEX 2973 SpCas9 episomal [58]
Synechocystis sp. PCC 6803 SpCas9 chromosomal [112]
Synechococcus elongatus PCC 7942
FnCas12a episomal [57]Synechococcus elongatus UTEX 2973
Nostoc sp. PCC 7120 FnCas12a episomal [113]
In contrast to Cas9, expression of Cas12a in the cyanobacterial strains examined so far does not
appear to result in toxicity [57,113,114]. Gene editing using Cas12a from Francisella novicida (FnCas12a)
has been demonstrated in PCC 6803, PCC 7942, UTEX 2973 and Nostoc PCC 7120. An additional
advantage of Cas12a is that the intrinsic RNase activity allows for the design of a single expression
cassette containing multiple gRNAs to target several DNA loci simultaneously (Figure 1C) [115–117].
A recent multiplexing study with Cas12a designed an array of 25 gRNAs on a single plasmid that
simultaneously edited multiple genomic target sites in mammalian cells [105].
Previously, reports of gene editing with FnCas12a in cyanobacteria have been limited to a single
lab [57,114]. However, Niu et al. [113] have recently also demonstrated that Nostoc PCC 7120 can be
edited by FnCas12a. A high efficacy was demonstrated for FnCas12a-mediated gene editing of single
target sites (83%) by attempting to generate knockout mutants in 26 different genes using 52 gRNAs (two
per gene) [113]. In addition, a markerless double-knockout mutant was generated for two genes required
for heterocyst formation (hetR (alr2339) and hetN (alr5358)) in a single step following co-conjugation
with two CRISPR/FnCas12a editing vectors carrying different antibiotic selection markers. Lastly,
a conditional knockout was generated for the essential gene polA (alr1254; DNA polymerase I) by
replacing the RBS of the polA promoter with a theophylline-induced riboswitch [118,119]. Successfully
transconjugated lines were only viable when grown with theophylline. Transconjugates were then
cured of the self-replicating CRISPR/FnCas12a vector by withdrawing antibiotics and using sacB
counter selection on sucrose plates.
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Table 4. The available PAM sequences for cyanobacterial species highlighted in this study for different Cas variants. Only species with full genomes available are
shown. The Cas variants indicated are Streptococcus pyogenes Cas9 (SpCas9), Francisella novicida Cas12a (FnCas12a), Acidaminococcus sp. Cas12a (AcCas12a, and
variants AsCas12a-RR and ASCas12a-RVR), Lachnospiraceae bacterium Cas12a (LbCas12a) and Deltaproteobacteria bacterium CasX (CasX). The average number of
PAM sites (in brackets) per kb of genome are shown (N = A, T, C, G; V = A, C, G; Y = C, T). Genome data was sourced from The European Nucleotide Archive
(https://www.ebi.ac.uk/ena) and The National Centre for Biotechnology Information (https://www.ncbi.nlm.nih.gov/genome).
Cyanobacteria Genome Size (bp) SpCas9 (NGG) FnCas12a (TTN) AsCas12a andLbCas12a (TTTV)
AsCas12a-RR
(TYCV)
ASCas12a-RVR
(TATV) CasX (TTCN)
Arthrospira platensis C1 6,089,210 134 168 24 46 21 33
Arthospira plantensis NIES 39 6,788,435 114 171 37 46 22 33
Chroococcidiopsis thermalis PCC 7203 6,315,792 89 175 38 41 17 34
Cyanothece sp. ATCC 51142 4,934,271 118 221 35 40 23 39
Cyanothece sp. PCC 7822 6,091,620 114 210 33 39 21 36
Gleobacter violaceus PCC 7421 4,659,019 170 89 17 42 6 26
Nostoc punctiforme strain ATCC 29133 8,234,322 114 194 43 40 20 35
Nostoc sp. PCC 7120 6,413,771 119 191 27 39 39 34
Synechococcus elongatus PCC 6301 2,696,255 142 113 10 41 7 28
Synechococcus elongatus PCC 7942 2,695,903 141 113 10 41 6 28
Synechococcus elongatus PCC 11801 2,691,022 139 115 10 41 7 29
Synechococcus sp. PCC 7002 3,008,047 153 163 22 48 11 33
Synechococcus sp. PCC 11901 3,081,514 152 163 22 47 11 33
Synechococcus sp. UTEX 2973 2,690,418 142 113 10 41 6 28
Synechococcus sp. WH 8102 2,434,428 173 86 7 49 4 28
Synechocystis sp. PCC 6803 3,569,561 161 174 23 51 12 32
Thermosynechococcus elongatus BP-1 2,593,857 176 126 13 42 10 27
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Thus far, FnCas12a is the only reported Cas12a used in cyanobacteria genome editing studies. One
general constraint of CRISPR/Cas editing is the specificity of the PAM site required for DNA cleavage.
Of potential interest to cyanobacterial researchers is the growing availability of different Cas12a isoforms
(e.g., AsCas12a and LbCas12a from Acidaminococcus sp. and Lachnospiraceae bacterium, respectively)
and those engineered to recognise alternative PAM sequences (Table 4) [96,120]. Increased flexibility in
PAM recognition will allow for more choice when targeting loci for genome editing [120,121]. New Cas
enzymes continue to be identified but remain to be evaluated in cyanobacteria, such as CasX, which
also produces a staggered DSB but is smaller than Cas12a [122]. If CasX is less toxic than Cas9, it may
provide a useful new set of tools for genome-editing in cyanobacterial species.
3.2. Serine Integrases for Generating Multiple Knock-ins
The most commonly used methods for genome engineering in cyanobacteria still rely on HR
and the use of selective markers. For example, to generate a gene knockout or a knock-in mutant,
heterologous DNA must be integrated with a selective marker (e.g., an antibiotic resistance cassette).
Thus, the ability to generate mutants in a given species with multiple insertional mutations is limited
by the availability and efficacy of selective markers. To overcome this limitation, several methods
have been developed for generating markerless mutants, which allows mutant strains to undergo
further genetic modifications. One of the most widely used markerless techniques in PCC 6803 uses
a two-step HR approach with the negative selection marker sacB, which produces levansucrase, an
enzyme conferring sensitivity to sucrose [16]. Nevertheless, generating a fully segregated markerless
mutant for a single locus takes ca. 4 weeks to several months, depending on the target locus, while
sequential engineering for multi-mutant strains can be very time consuming. Tsujimoto et al. [123]
demonstrated an insertion of 20.8 kb in PCC 6803, but this was achieved by a laborious five-step HR
process using ca. 4 kb at a time. Therefore, new methods need to be developed to allow large DNA
insertions and/or multiple loci engineering in a more efficient timeframe.
Serine integrases are a subfamily of the site-specific recombinases that catalyse DNA rearrangement
through small DNA sequences (<50 bp) called attachments (att) (commonly used for GateWay
cloning) [124]. Serine integrases catalyse recombination between the att sites from linear or circular
DNA that can result in excision, integration or inversion of DNA sequences, depending on the
position and orientation of the att sites. Temperate bacteriophages encode serine integrases to catalyse
integration of their DNA into bacterial genomes through recombination of attP (phage) and attB
(bacteria) attachment sites, generating attL (left) and attR (right) sites (Figure 2A). Serine integrases
bind to the attP and attB sites to make a staggered cut in the central region, generating halves with a two
base-pair 3′ overhang. Then, rotation takes place to swap the attP and attB half-sites and finally, the two
bp complementary overhangs religate to generate attR and attL sites that cannot recombine again unless
a recombination directionality factor (RDF) is present (Figure 2B). Six pairs of nonpalindromic central
overlap sequences (TT, CT, GT, CA, CC, and TC) can be used to create orthogonal sites and allows
multiple att sites to be used simultaneously (e.g., attPTT will only recombine with attBTT in a specific
orientation) [125]. The control of directionality and orthogonality have made serine integrases attractive
tools for genome engineering and genetic logic gate design [126,127]. In contrast to CRISPR/Cas-based
approaches, site-specific recombination using serine integrases does not rely on endogenous DNA
repair pathways, such as NHEJ or HR. Although CRISPR/Cas knock-in approaches are able to generate
small insertions in a single step, the size of the insertion remains limited by the efficiency of HR.
In addition, unlike Cas9, no toxicity has been reported with the usage of serine integrases in several
organisms [124,126,128].
Serine integrases have been used for genome engineering in a variety of organisms, including
mice [129], Drosophila melanogaster [130], S. cerevisiae, E. coli [126] and Clostridium ljungdahlii [128].
A recent strategy outlined a portable method to simplify the introduction of multiple genomic
insertions using the orthogonal att sites of the PhiC31 serine integrase [126]. Firstly, one or more
selective markers flanked by two orthogonal attB sites were integrated into the genome of E. coli as
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“landing pads”. Although Snoeck et al. [126] used HR to introduce the landing pads, other techniques
such as CRISPR/Cas have been used for att site integration [128]. Secondly, a donor vector carrying
an expression cassette for PhiC31 integrase and the DNA fragment(s) to be inserted flanked by attP
orthogonal sites was introduced to generate insertions specific for each corresponding landing pad by
attB × attP recombination (Figure 2C).
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Figure 2. Mechanism of action of serine integrases and knock-in strategies. (A) DNA rearrangement
with serine integrases: attB and attP sites recombine to make attL and attR sites. In the presence of
the cognate recombination directionality factor (RDF), the reaction is reversed [124]. (B) The serine
integrases bind to the attP and attB sites, generate a staggered 2 bp cut to produce two halves at
each site, and then rotate to swap the two halves from each site. If the halves are complementary,
relegation occurs to generate attL and attR sites. (C) A serine integrase-mediated knock-in strategy
for cyanobacteria. Integration of a landing pad (the landing pad shown carries orthogonal attBCC
and attBTT sites) occurs by homologous recombination (HR) at a neutral site in the cyanobacterial
chro oso e ( 1). self-replicating vector carrying the donor frag ent flanked by attPC and
att sites and a PhiC31 integrase expression cassette is introduced into the cyanobacterial strain (C2).
x ressi f i 31 i te rase res lts i t e rec i ati f t e rt al att a att airs ( 3),
re l ci t e l i it t e r t e er te r e c -i t t ( ).
Microorganisms 2019, 7, 409 15 of 36
Using a single landing pad, a 10.3 kb DNA fragment was inserted with 100% efficiency.
Simultaneous recombination with three landing pads generated a triple-knock-in mutant (all fragments
were ca. 2.5 kb in size), with an efficiency of 75%.
In cyanobacteria, integration of one or more landing pads at a given locus could proceed either by
a two-step HR approach if the species is naturally transformable [16], or by CRISPR/Cas-mediated
HR [114]. CRISPR/Cas could also be used to insert landing pads at multiple loci in a single step [113],
Broad host range vectors able to self-replicate in cyanobacteria (e.g., pPMQAK1) could be used
to construct the donor vector [35]. To generate a markerless knock-in mutant following serine
intergrase-mediated recombination, the donor vector could be cured from the strain by inclusion of the
negative selection marker sacB on the vector backbone. Thus, serine integrases could emerge as a useful
tool for the generation of multi-knock-in markerless mutants for large DNA fragments in cyanobacteria.
Generating a library of strains with att “landing pads” in combination with high-throughput assembly
methods, such as Golden Gate MoClo for the assembly of the donor vectors [35], could significantly
speed up the design-build-test cycle.
4. Known and Novel Tools for Regulating Gene Expression in Cyanobacteria
4.1. Gene Regulation with CRISPRi and Synthetic Small Regulatory RNAs
The emergence of CRISPR interference (CRISPRi) and synthetic small regulatory RNA (sRNA)
tools in cyanobacterial research has allowed for fine modulation of gene expression at both the
transcriptional and translational levels. For translational repression, sRNA tools employ an antisense
RNA to bind a specific mRNA transcript target and generate an RNA duplex [131,132]. The RNA duplex
suppresses translation and subsequently targets the mRNA transcript for degradation. sRNA-based
approaches have been demonstrated in PCC 6803 and PCC 7002, including a paired termini antisense
RNA approach and an Hfq-mediated system using sRNAs fused to a MicC scaffold [132–134]. Both
approaches demonstrated up to 90% reduction in protein expression.
For transcriptional repression, CRISPRi approaches make use of DNase-inactive variants of
Cas, called “dead” Cas9 (dCas9) or DNase “dead” Cas12a (ddCas12a; also known as ddCpf1)
(Figure 1D) [100,117]. To date, SpdCas9 is the only reported DNase-inactive Cas used in cyanobacterial
research, but it has been used successfully to repress gene expression in PCC 6803, PCC 7002, PCC 7942
and Nostoc PCC 7120 [35,133,135–138]. Unlike SpCas9, SpdCas9 does not appear to be toxic. However,
in our lab, we have observed a reduction in growth rates in PCC 6803 when SpdCas9 was expressed at
high levels, suggesting that low/medium strength promoters should be used when designing SpdCas9
expression cassettes. Decreased growth rates and changes in cell morphology and division have been
observed in E. coli when expressing SpdCas9 at high levels [139].
Multiplexing of gRNAs to target several genes simultaneously with SpdCas9 has been
demonstrated in PCC 6803 [137,140]. Kaczmarzyk et al. [137] demonstrated simultaneous repression
of six native genes. However, a potential limitation to multiplexing using dCas9 is the need for
individual expression cassettes for each gRNA. Kaczmarzyk et al. [137] reported issues with vector
recombination in PCC 6803 due to repeated use of common promoters and terminators for each gRNA
cassette. ddCas12a may provide an improvement over SpdCas9 in cyanobacteria for multiplexing
gRNAs and repression of multiple loci, as demonstrated in E. coli [117]. Cas12a requires a DR length of
19 base pair (bp) to generate mature gRNAs from spacer arrays [141], which is significantly less than
that of most promoters and terminators; this may help to reduce plasmid vector size requirements
and mitigate recombination issues when multiplexing is required. However, cloning spacer arrays
can be challenging due to the multiple repeated sequences, and is not always achievable even using
commercial DNA synthesis companies.
CRISPRi using SpdCas9 has been reported to reduce protein expression of heterologous reporter
genes (e.g., YFP) between 40% and 99%, depending on the gRNA(s) used [35,140]. Native gene
repression has been shown to vary, with a maximum reduction of 94% achieved for glgC in PCC
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7942 [136,140]. Yao et al. [136,140] targeted a range of native genes with CRISPRi in PCC 6803 and
observed reductions of <90% for slr0942, sll0990, and slr1192, but more modest knock down of 50%
for slr0091. Thus, validation of gRNA(s) is important to ensure effective transcriptional repression,
which can be time consuming. To achieve more robust and consistent down regulation, it may
be advantageous to combine CRISPRi and sRNA to simultaneously modulate transcription and
translation. Furthermore, CRISPR/Cas variants have been characterised that target RNA, and thus
also can modulate expression at the translational level. For example, Cas13 cleaves single-stranded
RNA [142], and in its deactivated form (dCas13), can bind mRNA and suppress translation [143].
Cas13 may provide additional tools for RNA manipulation and additional strategies for gene and
multigene repression studies.
Finally, dCas9 has also been used to drive gene expression by so called CRISPR activation
(CRISPRa). CRISPRa relies on gRNA(s) modified to include an extended hairpin sequence (termed
a scaffold RNA, scRNA) that function, for example, to recruit an RNA binding protein (RBP) fused
to a transcriptional activator [108]. Thus, when the dCas9-scRNA complex binds to a target locus,
the scRNA recruits the appropriate machinery to drive transcription (Figure 1E). As the dCas9 is
unmodified, CRISPRi and CRISPRa could be achieved concurrently with the expression of multiple
gRNAs and scRNAs for simultaneous gene repression and activation [108,144]. In E. coli, effective gene
activation by CRISPRa does require appropriately positioned PAM sites situated at specific locations
upstream of the transcription start site. Recent work shows that shifting the gRNA target site by as
little as two nucleotides can lead to a significant loss in activation [145]. Nevertheless, these approaches
could improve on current strategies in cyanobacteria to both express heterologous pathways and
repress native gene expression for the redirection of metabolic flux towards desired products [137].
4.2. Sigma Factors and RNA Polymerase as Regulatory Tools for Gene Transcription
The highlighted serine integrase recombination and CRISPR-based approaches are examples of
promising tools for genome engineering and gene regulation in cyanobacteria. However, applying
these approaches often requires careful regulation of the composite parts by inducible and, ideally,
orthogonal gene expression systems to generate predictable outputs [146–148].
Sigma factors are critical components required for transcription initiation in bacteria that interact
with the core RNA polymerase (RNAP) complex to facilitate binding to specific DNA promoter
regions [149]. Thus, different sigma factors are involved in driving the transcription of different subsets
of genes, and are themselves expressed by different environmental or stress inputs [150,151]. All
cyanobacterial sigma factors belong to the sigma 70 family [152], although several others exist in
bacteria [153].
Recent reports have provided good evidence that sigma factors may be compatible with RNAP
complexes from different bacterial species, paving the way for a potential novel orthogonal expression
system in cyanobacteria. Nostoc PCC 7120 contains twelve sigma factors that regulate gene expression
according to environmental conditions [154]. In a recent study, Wells et al. [155] tested the sigma factors
from Nostoc PCC 7120 in E. coli and observed that several cyanobacterial promoters were able to drive
transcription in E. coli only when sigma factors from Nostoc PCC 7120 were co-expressed. Similarly,
sigma factors from Bacillus subtilis can be co-expressed in E. coli to construct an orthogonal expression
system [156]. Thus, testing non-sigma 70 factors in cyanobacteria may help to identify novel tools for
orthogonal transcriptional regulation [157]. For example, E. coli have a sigma 54 factor [158,159], which
if functional in cyanobacteria, could allow for transcription from sigma 54-dependant promoters as a
novel orthogonal trans-acting expression system [152]. Liu et al. [160] have recently demonstrated in
E. coli that sigma 54-dependent promoters can be combined with CRISPRa and have a higher dynamic
range compared to sigma 70-dependent promoters.
Similarly, heterologous RNAP systems could be employed. For example, the T7 RNAP is a single
subunit RNA polymerase of viral origin that is commonly used as an expression tool in E. coli due to its
orthogonality to bacterial transcription machinery [161–163]. Use of T7 RNAP has also recently been
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demonstrated in PCC 6803 and PCC 7942 [164,165]. As in E. coli, native sigma factors in cyanobacteria
do not interact with the T7 promoter sequence (PT7), so genes driven by PT7 are transcribed only
if the cognate T7 RNAP is expressed. Directed evolution approaches have produced new variants
of T7 RNAP with altered promoter recognition characteristics [161,166]. PT7 has also undergone
substantial analysis, with Komura et al. [167] testing transcriptional activity of 7847 PT7 variants. T7
RNAP has also been adapted to act as a photoactivatable genetic switch in E. coli with dark-off/light-on
properties [168]. The latter system could be of use in cyanobacterial biotechnology; for example, light-
or dark-dependent control of protein production (e.g., for light-sensitive bioproducts) with a variety of
different promoter strengths.
4.3. The Potential of Optogenetic Systems
Several small-molecule inducible/repressible systems have been characterised in E. coli [169–171].
However, only a small number have been characterised in cyanobacteria, and thus far, only in model
species [31,37,164,172–174]. The commonly used lac operon induction system, which uses isopropyl
β–d-1 thiogalactopyranoside (IPTG), has been shown to be leaky and have low induction levels, possibly
due to the limited capacity of IPTG to diffuse into cyanobacterial cells [119,175,176]. Metal ion inducible
promoters have been tested in several cyanobacterial strains [177–179], but these are sometimes not
practical as many metals ions are present in standard growth media (e.g., BG11 [180]) and toxicity can be
an issue. More recently, an arabinose inducible and a rhamnose inducible promoter were characterised
in PCC 6803, which showed tight regulation, linear response and sustained expression [31,37]. However,
the relatively low availability of inducible/repressible systems in cyanobacterial species compared to
model heterotrophs still limits the progress and development of more advanced synthetic circuits for
dynamic control of cellular behaviour [108,181].
In the last decade, optogenetics (i.e., light-controlled regulation) has emerged as a promising
tool for tuning synthetic circuits in mammalian and bacterial cell systems [182–186]. Compared with
chemical induction systems, optogenetic systems allow for more targeted, rapid and precise control of
genetic elements with increased spatial and temporal control, while being minimally invasive and
reversible [187–190]. Optogenetic systems can be classified broadly into two-component systems
(TCSs) or one-component systems (OCSs).
An optogenetic TCS requires two elements: a light-sensing module and a light-responsive module
that is activated by the light-sensing module. For example, the green light-inducible CcaS/CcaR TCS in
PCC 6803 relies on the membrane-bound histidine kinase CcaS (i.e., the light-sensing module), which
is phosphorylated in green light (Figure 3A) [191]. Phosphorylated CcaS subsequently phosphorylates
the cytosolic response regulator protein CcaR (i.e., the light-responsive module) that, in turn, activates
the expression of the phycobilisome linker gene cpcG2. TCSs have been identified in plants [192],
bacteria [191] and fungi that specifically sense UV [193], blue [194,195], green [196–198], red [199]
or near-infrared light [200]. In contrast, optogenetic OCSs act as both the sensing and responsive
modules and are found in the cytosol. So far, only the blue light-activated OCSs that belong to the LOV
(Light–Oxygen–Voltage) family of proteins have been characterised in heterotrophic bacteria [187,201],
S. cerevisiae [186,202] and Arabidopsis thaliana [203] (Figure 3B,C). Both systems have been used in the
control of genetic circuits at multiple levels, such as transcription and protein activity.
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Figure 3. Examples of optogenetic two-component and one-component systems. (A) The
two-component green light-inducible CcaS/CcaR system native to Synechocystis sp. PCC 6803.
In the presence of green light (535 nm), the histidine kinase CcaS is phosphorylated and, in turn,
phosphorylates the response activator CcaR, which results in expression of cpcG2 [191,196]. (B) The
EL222 transcription factor from Erythrobacter litoralis HTCC2594 is a one-component system. Blue light
induces a conformational change between the LOV and the Helix-Turn-Helix (HTH) DNA binding
domain, allowing dimerisation and DNA binding [187]. (C) Split T7 RNA polymerase (RNAP) fused to
the Vivid (VVD) photoreceptor from Neurospora crassa is a one-component system. In blue light, the
two subunits of VVD (nMag and pMag) interact to assemble the split T7 RNAP (T7 RNAPNT and T7
RNAPCT) as a functional RNA polymerase [204].
Apart from the green light-inducible CcaS/CcaR system, only one other optogenetic TCS has been
characterised in PCC 6803, the near-UV activated UirS/UirR system that regulates phototaxis [205].
The latter has not yet been exploited in cyanobacterial research, but the CcaS/CcaR system has been used
in PCC 6803 to regulate GFP expression [196], and drive expression of two T4 phage-derived lysis genes
to generate a green light-induced cell membrane lytic system [197]. The CcaS/CcaR system has also
been used to modulate GFP in a marine species where the CcaS/CcaR system is absent (Synechococcus
sp. NKBG 15041c), and demonstrated tight repression under red light and a 20-fold induction of GFP
under green light [206]. Thus, cyanobacterial TCSs show promise as tools for transcriptional control in
species where those TCSs are not present.
There are also several optogenetic systems characterised in E. coli that could be used
in cyanobacterial research. For example, the near-infrared (760 nm) TCS BphP1/PpsR2 from
Rhodopseudomonas palustris showed rapid response dynamics and a 2.5-fold dynamic range [200].
Recently, an OCS based on the Vivid (VVD) photoreceptor from the filamentous fungus Neurospora
crassa was used to generate a blue-light-inducible T7 RNAP system (Figure 3B) [204]. In the dark, only
low levels of gene expression were observed, while high levels of expression were achieved in blue
light (460 nm), with an inducible range of >300-fold. Optogenetic systems responsive to different
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light wavelengths can also be combined to achieve multichromatic gene control [199]. For example, a
red–green–blue (RGB) system was constructed in E. coli for production of three different pigments to
generate colour biophotographs [188]. The RGB system used a fragmented T7 RNAP that could bind
to specific promotors depending on the light input, and demonstrated little crosstalk, high dynamic
range and fast responses when induced.
Currently, the main challenge for porting optogenetic systems into cyanobacteria is ensuring
compatibility with native light-responsive components. Cyanobacteria naturally produce many of
the cofactors required for light-sensing and light-responsive modules [207], which could provide
an advantage when porting heterologous optogenetic systems. However, growing cyanobacteria
in specific wavelengths (e.g., blue, green, orange, red) will affect photosynthetic efficiencies and
growth [208]. Therefore, optimising optogenetic systems might require testing several sources of light
to limit any impacts on photosynthesis and achieve the desired outputs.
4.4. Using Inteins to Progress Genetic Circuit Research in Cyanobacteria
Genetic circuits occur in nature and form the basis by which living cells respond and adapt to
the surrounding environment [146]. A key goal in synthetic biology is the generation of synthetic
genetic circuits that operate as Boolean logic functions to give digital-like control over gene expression
in response to environmental stimuli [146,209,210]. Basic Boolean logic functions include ‘AND’ and
‘NOT’ gates: AND gates will give an output signal if all inputs are ‘ON’, while NOT gates will give an
output signal only if all inputs are ‘OFF’ [147,211,212]. To date, relatively few synthetic genetic circuits
have been constructed in cyanobacteria [213]. These include an oxygen-responsive AND gate in PCC
6803 [214] and four NOT gate variants in PCC 6803, PCC 7942, Nostoc PCC 7120, Synechocystis sp.
WHSyn, and Leptolyngbya sp. BL0902 [73]. Currently, two key constraints for making more complex
synthetic genetic circuits in cyanobacteria are the relatively small number of characterised inducible
expression systems available, and the limited means to integrate multiple input signals (i.e., from
different inducible systems) into a single output [215]. Thus, new tools (such as those highlighted in
this review) will be required.
Inteins are naturally occurring polypeptides (100–150 amino acids) within a larger precursor
protein that can excise themselves spontaneously from flanking protein regions (exteins (external
proteins)) [216]. Inteins have been identified in several cyanobacteria [217], and a variety of other
organisms, including other bacterial species, archaea, viruses and eukaryotes [218,219]. Intein excision
involves the cleavage of two peptide bonds, resulting in the formation of a new peptide bond,
which ligates the flanking exteins together, forming a newly rearranged protein. This auto-catalytic
posttranslational modification is referred to as protein splicing and it exists in two forms, cis- and
trans-splicing [220]. In the former, the intein coding sequence is embedded in frame with the gene,
such that the precursor protein is produced from a single mRNA transcript and translated as two
exteins flanking the intein. Upon cis-splicing, the intein is excised from the precursor protein and the
flanking exteins are ligated seamlessly to form a new protein. In contrast, trans-splicing events are
facilitated by two precursor proteins translated from separate mRNAs, where each encodes a “split
intein” fragment (i.e., an N-intein half and a C-intein half) fused to an extein (Figure 4). When the
precursor proteins are brought into close proximity, the split inteins re-assemble non-covalently [221].
Trans-splicing then occurs, resulting in excision of the split inteins and ligation of the exteins via a
covalent bond to generate an intact protein [221,222].
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Split inteins have been used in E. coli to construct a functional two input transcriptional AND gate
system using a split T7 RNAP approach [222]. T7 RNAP was separated into two domains, each fused
to an N- or a C-intein half, and expressed from two different inducible promoters. Schaerli et al. [222]
showed that expression of both T7 RNAP domain-intein fusions was required to reconstitute a functional
T7 RNAP and drive transcription of GFP from PT7. Using a similar trans-splicing approach, split
inteins have also been used to facilitate re-assembly of split variants of the more complex multidomain
transcriptional regulator TetR [223]. Like T7 RNAP, TetR repressible systems have been used in PCC
6803 and PCC 7942 [164]. Thus, these split intein-based gate systems may be straightforward to
port into cyanobacteria, provided that the inteins used are orthogonal (i.e., not of cyanobacterial
origin) [224]. Split intein strategies could also be used for other transcription factors successfully trailed
in cyanobacterial species (e.g., LacI, AraC and RhaS [37,176,214,225]) to construct larger synthetic
genetic circuits.
5. Genome-Scale Models
Manipulating cyanobacteria for biotechnology applications is dependent not just on developing
better genetic tools but also improving our understanding of cellular metabolism. Genome-scale
models (GSMs) are large-scale simulation tools that comprise a global description of the metabolic
reactions and pathways of an organism using stoichiometric coefficients and mass balances of the
participating metabolites [226]. GSMs are receiving increasing interest due to their predictive power
in metabolome and flux changes, thereby making them a valuable tool in metabolic engineering
approaches and optimisation for enhanced production of target metabolites [227,228].
Currently, 290 draft genomes and 85 full genomes are available for cyanobacterial species [39].
However, GSMs have only been developed for a small number of these, primarily models such
as PCC 6803 [42], PCC 7942 [41] and more recently, UTEX 2973 [43] (Table 5). GSMs from model
species can be used as a scaffold to draft GSMs for other cyanobacterial species, as many pathways
are conserved [229]. Generating robust and accurate GSMs is an iterative and bottom-up process
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dependent on the expansion and updating of draft models with available experimental data. Thus,
GSM models are continually being improved due to the growing availability of sequencing and
omics information.
Table 5. Genome-scale models currently available for different cyanobacterial strains.
Cyanobacteria GSM Name Reference
Synechocystis sp. PCC 6803 iSynCJ816 [230]
imSyn716 [42]
Synechococcus sp. PCC 7942 iSyf715 [231]
iJB785 [41]
iJB792 [232]
Synechococcus sp. UTEX 2973 iSyu683 [233]
imSyu593 [43]
Synechococcus sp. PCC 7002 iSpy708 [234]
iSpy821 [235]
Arthrospira platensis NIES-39 n/a [40]
Nostoc sp. PCC 7120 n/a [236]
Recent cyanobacterial GSMs have attempted to include algorithms to model components of
the photosynthetic electron transport chain [41,230,232,235]. However, representing the mechanisms
of light capture and electron flow in stoichiometric coefficients is challenging as fluxes cannot be
determined experimentally by standard methods (e.g., 13C metabolic flux analysis) [41,237,238].
The model iJB785 for PCC 7942 incorporates the impact of light availability on metabolic flux [41].
When used to estimate whether genes were essential or non-essential for survival, the model achieved
an accuracy of 78% based on previous experimental data [239]. Recently, the PCC 7942 model was
updated (i.e., iJB792) to include whole-cell light absorbance and the rate of photosynthetic O2 evolution
to predict metabolic reaction fluxes [232]. The updated model demonstrated a 98% correlation between
simulated and experimental metabolic fluxes under low- (60 µmol photons m−2·s−1) and high-light
(600 µmol photons m−2·s−1) conditions. Similarly, the model iSynCJ816 for PCC 6803 can account for
changes in energy absorption for different light qualities [230], and achieved a 77% accuracy when
compared with experimental results from online databases and literature searches. In comparison,
the latest GSM for E. coli (iML1515) can predict gene essentiality in minimal media with 16 different
carbon sources with an average accuracy of 94% [44]. The relatively higher accuracy of iML1515
relies on the integration of biochemical, physiological, localisation, genetic, transcriptomic, proteomic
and fluxomic data. Currently, protein localisation and transcriptomic data are not included in GSMs
for cyanobacteria.
Cyanobacterial GSMs have been used to detect key metabolic differences between species [240]
and to identify bottlenecks for the biosynthesis of relevant metabolites [241]. These include a composite
GSM for the closely related strains, PCC 7942 and UTEX 2973, based on the model inSyn617 for PCC
6803. The resulting model (iSyu683) identified pathways where resources were allocated differently
between PCC 7942 and UTEX 2973, the most prominent difference being carbon uptake rates [233].
An improved model for UTEX 2973 (imSyu593) was recently developed using transient 13C-labeling.
The flux elucidation revealed nearly complete conversion (>96%) of the assimilated carbon into
biomass compared with only 86% conversion in PCC 6803. Comparison of the UTEX 2973 flux
map with that of PCC 6803 revealed differences in the synthesis of key Calvin cycle metabolites,
fructose-6-phosphate and sedoheptulose-7-phosphate, and production of amino acids, glycine and
serine, from the photorespiratory salvage pathway [43].
GSMs can be used in cyanobacteria to improve bioproduction. Recently, the model iBJ792
for PCC 7942 was used to determine an optimal solution in silico to maximise the production of
2,3-butanediol [232]. GSMs can be also be combined with other computational tools for production
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optimisation. For example, OptFlux and OptForce are software tools that identify all possible
engineering interventions by determining what genes to knock out, or which reaction fluxes in a
model need to increase, decrease or fall to zero, to overproduce specific metabolites [242,243]. OptFlux
has been combined with GSMs in PCC 6803 to improve the production of n-butanol [138]. OptFlux
confirmed that genes targeted for manipulation based on previous experimental data were essential
for growth. Subsequent repression of the gene targets arrested growth and redirected carbon flux
towards the production of n-butanol, resulting in a 5-fold yield increase compared to the non-repressed
strain. Similarly, OptForce was used to increase the production of limonene [244]. Overexpressing
three predicted gene targets (two involved in the pentose phosphate pathway and geranyl diphosphate
synthase) resulted in a 2.3-fold improvement in limonene production in vivo.
Further improvements in the accuracy of GSMs in cyanobacteria are constrained by the lack of
available omics data. For example, a large percentage of the predicted proteins in most cyanobacterial
genomes are still annotated as unknown or hypothetical [245]. In addition, transcriptomic data and
transcriptional regulatory mechanisms are not integrated in current cyanobacterial GSM models, unlike
those for other species such as E. coli (iML1515) [44,246]. Lastly, incorporation of more accurate models
for photosynthesis, light-harvesting and electron transport is required [232]. The current expansion of
high-throughput omics technologies and automated cloning facilities (e.g., genome foundries) can
be used to generate large amounts of experimental data under different growth conditions, which
promises to help overcome current limitations for cyanobacterial GSMs.
6. Development of CyanoSource: A Barcoded Mutant Library for Synechocystis sp. PCC 6803
Mutant generation is a key tool in bacterial research and for altering species for biotechnology
applications. Individual research laboratories currently generate mutants of interest via a variety
of different experimental methods, using a range of plasmid systems in sub-strains that can vary
significantly at both the phenotypic and genotypic level (e.g., in PCC 6803 [247–249]). This raises
the issue of whether studies are directly comparable, a key concern given the growing emphasis on
reproducibility within the scientific community. The construction of mutant libraries is a consistent
and efficient method for the study of protein properties, regulation and function. Mutant libraries
have been generated for model photosynthetic eukaryotes, such as Chlamydomonas reinhardtii [250]
and Arabidopsis thaliana [251], and model microbial species including E. coli [252] and S. cerevisiae [253].
The existence of mutant libraries accelerates the pace of research, avoids unnecessary replication
between research groups and helps to improve experimental designs. Targeted mutant libraries also
provide knowledge on the essential gene set required for survival, further avoiding wasteful laboratory
replication [239]. In addition, many research groups, particularly in developing countries, lack the
expertise and resources to generate cyanobacterial mutants.
Cyanobacteria remain underdeveloped for fundamental research and viable biotechnological
exploitation. Nevertheless, cyanobacterial research is a rapidly growing field with approximately
13,000 new papers published in the last 5 years, making it the third most studied group of autotrophs
behind plants and algae. In PCC 6803, only ca. 1050 coding sequences (~30%) have assigned
functions, compared to ~80% in E. coli and S. cerevisiae [226]. Of these, only a small proportion have
been characterised in a cyanobacterium [39]. The majority have been assigned functions based on
studies of homologues in other bacteria, even though the function and importance of characterised
genes may differ significantly between phototrophic and heterotrophic bacteria. Transposon libraries
have been reported for two model cyanobacterial species [239,254], but these suffer from common
issues associated with transposon mutagenesis, including random large insertions, pleiotropic effects,
incomplete saturation of the genome and difficulty in recovering individual mutants of interest.
A publicly available genome-wide collection of gene knockout mutants would generate a much-needed
step change in resource availability and significantly accelerate research in functional genomics and
cellular processes in cyanobacteria. It would also supplement existing algal and plant resources,
allowing researchers to further examine genes conserved across the photosynthetic lineage.
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Gene characterisation studies remain challenging and time-consuming but recent developments
in automation [255] can streamline and shorten the process of one of the major experimental hurdles:
generation of targeted mutants in which the gene of interest has been deleted. DNA assembly and
bacterial transformation are complex manual tasks that are time consuming and can suffer from high
error rates. Investment by the UK Research and Innovation councils in automated DNA Foundry
technologies has provided an opportunity to overcome these challenges [255]. In collaboration with
the Earlham DNA Foundry (EDF) and the Edinburgh Genome Foundry (EGF) we will carry out
the generation of the plasmids and mutants for this library by using a recently established MoClo
system for cyanobacteria [35]. This resource, termed CyanoSource, will target 3456 genes in PCC 6803
(Figure 5). Conditional mutants (i.e., specialised mutants that require an external stimulus to repress
a gene) will be constructed for essential genes that cannot be removed. Here, where appropriate,
we will use a copper-sensitive promoter that switches off the gene when copper is present [256–258].
For the cyanobacterial community, a genome-wide library of mutants and genetic parts generated via
automation will guarantee a standard of quality control not otherwise achievable.
In addition to automation, this library will be barcoded to allow for the tracking of individual
strains within a pooled mutant library. This powerful approach has been described in S. cerevisiae [253]
and C. reinhardtii [250], where barcoded libraries can be subjected to different conditions and the relative
fitness of individual mutants in a population can be determined via deep sequencing. Construction of
this library will begin in November 2019. All plasmids and mutants will be made available to UK and
international researchers via a public database, which will be updated throughout the project.
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Figure 5. Workflow for the automated production of the CyanoSource resource at two UK DNA 
Foundry facilities. Primers (1) will be used to generate amplicons carrying BsaI sites (red) and 
appropriate four-nucleotide overhangs (blue, boxed) for MoClo assembly. PCR products will then be 
purified and validated (2) and used to assemble suicide vectors (3) for natural transformation of 
Synechocystis sp. PCC 6803. Vectors will be sequenced by MiSeq (4) and glycerol stocks made for long-
term storage (5). PCC 6803 mutants will be generated (6), followed by several rounds of re-streaking 
to produce segregated mutants that will be confirmed by colony PCR (7), and stored as glycerol stocks 
(8). For distribution, plasmid stocks are planned to be supplied by Addgene and mutants supplied by 
the University of East Anglia CyanoSource Hub as streaked plates from glycerol stocks (9). 
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6803. Ve tors will be sequenced by MiSeq (4) and glycerol stocks made for long-term storage (5). PCC
6803 mutants will be generated (6), followed by several rounds of re-streaking to produce segregated
mutants that will be confirmed by colony PCR (7), and stored as glycerol stocks (8). For dist ibu ion,
plasmid stocks are planned to be suppli d by Addgen and mutants supplied by the University of East
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7. Conclusions
Given the ongoing advances in complex synthetic biology tools to finely modulate metabolism
in microbes, the future looks bright for progressing both fundamental and applied cyanobacterial
research. The topics outlined in this review highlight just some of the current exciting methods that
could be used to generate a step change for cyanobacteria researchers by improving transformation
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efficiencies, gene regulation and capacity for metabolic engineering. Development of the techniques and
resources outlined in this review should significantly improve our knowledge of this environmentally
important phylum, especially for poorly characterised species. Moreover, their application towards the
development of cyanobacteria as a renewable biotechnology platform could have immense implications,
not just commercially but also in replacing polluting fossil fuels usage for chemical production and
reducing carbon emissions.
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